Skip to content
OpenCapital
Get started

Oncolytics Biotech, Inc. ONCY Q4 2025 Annual earnings

Reported March 30, 2026 · Before market open

EPS-$0.08Miss by $0.02
EPS estimate-$0.06

Next report

Aug 14, 2026 (In 2 weeks)
EPS estimate-$0.07

Versus estimates

Diluted EPS

Q1 2026-$0.08Miss by $0.03
Q4 2025-$0.08Miss by $0.02
Q3 2025-$0.10Beat by $0.02Q2 2025-$0.05Beat by $0.06Q1 2025-$0.06Beat by $0.03Q4 2024-$0.07Beat by $0.01

Ask the moment Oncolytics Biotech, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Oncolytics Biotech, Inc. report Q4 2025 earnings?
Oncolytics Biotech, Inc. (ONCY) reported Q4 2025 earnings on March 30, 2026 before market open.
What were Oncolytics Biotech, Inc.'s Q4 2025 revenue and EPS?
Oncolytics Biotech, Inc. reported eps of $-0.08 for Q4 2025.
Did Oncolytics Biotech, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.06 by $0.02.
How did Oncolytics Biotech, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 14.3% from $-0.07.
Where can I find Oncolytics Biotech, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-038272) and the 10-K periodic report (0001129928-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.